Sep-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the province of Alberta, Noon & Night has shown a consistent presence in the Topical category. Despite experiencing a drop from 5th to 8th place from June to July 2024, the brand managed to recover slightly, maintaining the 7th position in both August and September. This indicates a stabilizing trend after a temporary dip. The sales figures reflect this movement, with a notable decline from June to July, followed by a modest increase in August, and then a slight decrease again in September. This pattern suggests that while Noon & Night remains a recognized name in the Alberta Topical market, there are fluctuations that may be worth monitoring for stakeholders interested in market dynamics.
The absence of Noon & Night from the top 30 rankings in other states and categories highlights potential areas for growth or concern. Being unranked in these additional markets could indicate either a strategic focus on Alberta or challenges in penetrating other regions or categories. Such insights can be crucial for understanding the brand's overall market strategy and performance. Observing these trends over time could provide a clearer picture of Noon & Night's strengths and areas that may require strategic adjustments, especially if they aim to expand their footprint beyond Alberta.
Competitive Landscape
In the Alberta topical cannabis market, Noon & Night has experienced notable fluctuations in its rank over the past few months, indicating a dynamic competitive landscape. Starting strong in June 2024 with a rank of 5, Noon & Night saw a drop to 8 in July, before stabilizing at 7 in both August and September. This shift in rank can be attributed to the competitive pressures from brands like LivRelief and Wildflower, which consistently maintained higher ranks, with LivRelief reaching as high as rank 5 in September. Despite these challenges, Noon & Night's sales figures reveal a downward trend, contrasting with the upward sales trajectory of LivRelief, which could suggest a need for strategic adjustments in marketing or product offerings to regain market share. Meanwhile, RHO Phyto briefly appeared in the rankings in July, underscoring the competitive volatility in this category. For Noon & Night, understanding these dynamics is crucial for crafting strategies to enhance its competitive positioning in Alberta's topical market.
Notable Products
In September 2024, the top-performing product for Noon & Night was the CBD/THC 10:1 Lavender Fizz Bath bomb (100mg CBD, 10mg THC) in the Topical category, maintaining its first-place rank consistently since June 2024, with sales reaching 670 units. The CBD Freshly Minted Roll-On (200mg CBD, 9.2ml) held the second spot, showing stable performance over the past few months. The CBD Bath Fizz Collection Bath Bombs 3-Pack (300mg CBD) ranked third, while the CBD Shinrin Yoku Fizz Bath Bomb (100mg CBD) remained in fourth place, both maintaining their positions from previous months. A newcomer, the CBD Omega-3 Softgels 30-Pack (900mg CBD) in the Capsules category, entered the rankings at fifth place in September, indicating a potential area for growth. Overall, the top products have shown a consistent trend in their rankings, with the introduction of the CBD Omega-3 Softgels adding some new dynamics to the sales figures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.